Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


APG and LSP announce strategic investment relationship


Amsterdam, April 28, 2008

The LSP (Life Sciences Partners) Group, the European life sciences investment group, today announces the establishment of a strategic investment relationship with APG Investments. With assets under management of over €200 billion, APG Investments is one of the world’s largest pension asset managers. APG Investments has entered into this relationship to further strengthen its expanded focus on the European publicly listed small-cap biotech market.

“The fact that a party like APG Investments has chosen LSP as its partner for European public biotechnology investments is a strong validation of our work in the European biotechnology arena” says Mark Wegter, General Partner at LSP and responsible for the firm’s recently established public biotech franchise. “The relationship with APG Investments is based upon our joint belief that the highly innovative and hugely dynamic biotechnology sector requires specialized investment expertise and knowledge. This is exactly what LSP brings to the equation.”

“We are enthusiastic about establishing this strategic relationship with LSP.”, says Martin Eijgenhuijsen, Senior Portfolio Manager Healthcare at APG Investments. “We are increasing our investment focus on publicly listed European small-cap biotechnology companies. APG Investments believes that Europe is an increasingly fertile location for biotechnology companies and the LSP team’s skills and expertise in healthcare investing make them a strong partner.”

Based in Amsterdam, Munich and Boston, the LSP Group has successfully invested in the biotechnology sector for almost two decades. Since inception, LSP has invested in 50 companies, of which many became leaders in the industry. With in-depth in-house knowledge and expertise in place as well as an extensive scientific, medical and financial network, LSP currently has € 400 million in capital under management, all of which is directed at investing in the life sciences sector. LSP has established itself among the leading life science investors in Europe. For more information about the LSP Group, please visit its website at

www.lspvc.com.


APG is an independent pension services company based in the Netherlands. APG Investments is a division of APG, All Pensions Group.

APG Investments manages more than €200 billion and it is one of the largest managers of pension assets in the world. APG promotes the pension interests of 2.7 million Dutch citizens and more than 4000 Dutch employers. APG employs 2500 people, 450 of which are active in asset management. APG has offices in the Netherlands in Amsterdam and Heerlen. For more information about APG, please visit its website at www.apg.nl.


For more information please contact


Mark Wegter (LSP) at + 31 20 664 55 00 or via mwegter@lspvc.com
Michel Meijs (APG) at + 31 45 579 81 00 or via michel.meijs@apg.nl


Publisher Contact Information:

Life Sciences Partners (LSP)
+ 31 20 664 55 00
mwegter@lspvc.com

Company profile of Life Sciences Partners (LSP)
Past press releases of Life Sciences Partners (LSP).

Data


25,720
Tech investments
From our Online Data Service
16,652
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
May 17€4.0MBiopharmaceuticals
May 16€15.0MPayment software
May 16€4.0MInternet services
May 16€80.0MConsumer electronics
May 16€6.3MImaging
May 16€13.0MInternet services
May 16€34.5MBiotechnology

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.